Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial

OBJECTIVE: The aim of this study was to test the safety of diazoxide and to search for signs of efficacy in patients with relapsing-remitting multiple sclerosis (RRMS). METHODS: In this multicenter, randomized, placebo-controlled, double-blind trial (treatment allocation was concealed), 102 patients...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurol Neuroimmunol Neuroinflamm
Main Authors: Villoslada, Pablo, Rovira, Alex, Montalban, Xavier, Arroyo, Rafael, Paul, Friedemann, Meca-Lallana, Virginia, Ramo, Cristina, Fernandez, Oscar, Saiz, Albert, Garcia-Merino, Antonio, Ramió-Torrentà, Lluís, Casanova, Bonaventura, Oreja-Guevara, Celia, Muñoz, Delicias, Martinez-Rodriguez, Jose Enrique, Lensch, Eckart, Prieto, Jose Maria, Meuth, Sven G., Nuñez, Xavier, Campás, Clara, Pugliese, Marco
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2015
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4567455/
https://ncbi.nlm.nih.gov/pubmed/26405686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000147
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares